Dapagliflozin (Forxiga庐) Versus Glipizide As Add-On Therapies In Type 2 Diabetes Mellitus (T2dm); An Update of The Cost-Effectiveness Based On Long-Term Clinical Evidence From Uk Nhs PerspectiveCharokopouVioixVerheggenB.GDillonFranks
\\{PDB56\\} - The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Glipizide in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Walesdoi:10.1016/j.jval.2013.08.677M. Charokopou and P. McEwan and S. Lister and L. Callan and K. Bergenheim and K. Tolley and M...